Real-world data on adjuvant capecitabine after standard neoadjuvant chemotherapy for triple negative breast cancer

• Prif Awduron: Maria Fernanda Imperio Pereira (Awdur), Isabela Panzeri Carlotti Buzatto (Awdur), Hélio Humberto Angotti Carrara (Awdur), Fabiana de Oliveira Buono (Awdur), Jurandyr Moreira de Andrade (Awdur), Leonardo Fleury Orlandini (Awdur), Daniel Guimarães Tiezzi (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Federação Brasileira das Sociedades de Ginecologia e Obstetrícia, 2024-08-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Abstract Objective Neoadjuvant chemotherapy (NACT) has become the standard of care for patients with triple-negative breast cancer (TNBC) with tumors > 1 cm or positive axillary nodes. Pathologic complete response (pCR) has been used as an endpoint to select patients for treatment scaling. This s...